Cite

HARVARD Citation

    Hasler-Strub, U. et al. (2023). Eribulin as first-line treatment in older patients with advanced breast cancer: A multicenter phase II trial [SAKK 25/14]. Journal of geriatric oncology. 14 (1), p. . [Online]. 
  
Back to record